Skip to main content

Impact of antifungal treatment in ICU patients with Candida colonization: analysis of the EPIC II study population

Introduction

We wished to evaluate the impact of receiving antifungal therapy in ICU patients with Candida colonization.

Methods

EPIC II recruited 1,265 ICUs in 76 countries. Patient characteristics were collected on the study day. Outcome data were assessed at ICU and hospital discharge. Patients colonized with Candida spp. were classified as having received antifungal treatment or not (*P < 0.05 compared between groups). Numerical values are reported as mean ± SD and length of stay (LOS) data as median (IQR).

Results

A total of 13,796 adult patients were in participating ICUs on the study day. Of these, 371 were classified as colonized. Differences in patient characteristics and outcomes are reported (Table 1). Baseline characteristics were similar in colonized patients treated with antifungal therapy compared to those that were untreated. Only a modest difference in the length of stay in the ICU prior to study day (25 (14, 40) vs. 21 (8, 43)) and utilization of mechanical ventilatory support (76% vs. 63%) was noted in the treated compared to the untreated patients with Candida colonization (P < 0.05). Despite the relatively similar baseline characteristics and equivalent severity of illness scores, treated patients had an increased ICU (35.3 vs. 22.3%) and hospital (41.0 vs. 27.7%) mortality (P < 0.05).

Table 1 Patients with Candida colonization: characteristics and outcomes

Conclusion

As colonized patients receiving antifungal treatment had significantly higher mortality, our data do not support the routine use of antifungal therapy in ICU patients based solely on colonization.

References

  1. 1.

    Vincent JL, et al.: JAMA. 2009, 302: 2323-2329. 10.1001/jama.2009.1754

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to D Kett.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Cite this article

Kett, D., Dimopoulus, G., Azoulay, E. et al. Impact of antifungal treatment in ICU patients with Candida colonization: analysis of the EPIC II study population. Crit Care 16, P59 (2012). https://doi.org/10.1186/cc10666

Download citation

Keywords

  • Public Health
  • Adult Patient
  • High Mortality
  • Baseline Characteristic
  • Emergency Medicine